251 related articles for article (PubMed ID: 6221530)
21. Inhibition of arachidonate-induced human platelet aggregation by a single low oral dose of aspirin in combination with a thromboxane synthase inhibitor.
Cerletti C; Rajtar G; Bertelé V; de Gaetano G
Thromb Haemost; 1984 Oct; 52(2):215. PubMed ID: 6441306
[No Abstract] [Full Text] [Related]
22. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
Uotila P; Matintalo M
Prostaglandins Leukot Med; 1984 Apr; 14(1):41-6. PubMed ID: 6427791
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
24. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
[TBL] [Abstract][Full Text] [Related]
25. Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid.
Tod ML; Cassin S
J Appl Physiol (1985); 1985 Mar; 58(3):710-6. PubMed ID: 3920192
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of thromboxane synthetase inhibitors.
Aiken JW
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():253-8. PubMed ID: 6221532
[No Abstract] [Full Text] [Related]
27. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
Mehta J; Mehta P; Ostrowski N
Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
[TBL] [Abstract][Full Text] [Related]
28. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of selective inhibitor of thromboxane synthetase (OKY-046) and thromboxane antagonist (ONO-3708) on ischemia-induced mitochondrial dysfunction in canine heart.
Ito T; Ito Y; Torii T; Hieda N; Toki Y; Miyazaki Y; Hashimoto H; Ogawa K; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():392-6. PubMed ID: 2959085
[No Abstract] [Full Text] [Related]
30. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
Gresele P; Blockmans D; Deckmyn H; Vermylen J
J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
[TBL] [Abstract][Full Text] [Related]
31. Effects of selective thromboxane synthetase inhibitor and indomethacin on prostacyclin and thromboxane A2 from ischemic canine heart.
Ogawa K; Sakai K; Ito T; Watanabe J; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():371-6. PubMed ID: 6221548
[No Abstract] [Full Text] [Related]
32. Inhibition of thromboxane responses in the airway of the cat by SQ29,548 and OKY 1581.
Kadowitz PJ; McNamara DB; Tilden SJ; Hyman AL; Underwood DC
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():535-8. PubMed ID: 2526533
[No Abstract] [Full Text] [Related]
33. Selective thromboxane synthetase inhibitor and ischemic heart disease.
Ito T; Ogawa K; Watanabe J; Chen LS; Shikano M; Imaizumi M; Shibata T; Ito Y; Miyazaki Y; Satake T
Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
[No Abstract] [Full Text] [Related]
34. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade, combined in one molecule.
De Clerck F; Beetens J; de Chaffoy de Courcelles D; Vercammen E; Freyne E; Janssen PA
Prog Clin Biol Res; 1989; 301():567-72. PubMed ID: 2529556
[No Abstract] [Full Text] [Related]
35. [The effect of thromboxane (Tx)A2 synthetase inhibitor (OKY-046) on airway hyperresponsiveness induced by ozone exposure in beagles].
Kobayashi H; Adachi M; Satoh H; Okada Y; Takahashi T; Yamaguchi H
Arerugi; 1985 Jul; 34(7):469-73. PubMed ID: 4062570
[No Abstract] [Full Text] [Related]
36. Effects of thromboxane synthetase inhibitors on aggregation of rabbit platelets.
Naito J; Komatsu H; Ujiie A; Hamano S; Kubota T; Tsuboshima M
Eur J Pharmacol; 1983 Jul; 91(1):41-8. PubMed ID: 6413227
[TBL] [Abstract][Full Text] [Related]
37. Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.
Szczeklik A; Dworski R; Nizankowska E; Gajewski P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1073-9. PubMed ID: 2960148
[TBL] [Abstract][Full Text] [Related]
38. RS-5186, a novel, long-acting thromboxane synthetase inhibitor.
Matsuda K; Ushiyama S; Ito T; Asai F; Oshima T; Ikeda T; Nakagawa A; Terada A; Yamazaki M
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():674-7. PubMed ID: 2526559
[No Abstract] [Full Text] [Related]
39. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
[TBL] [Abstract][Full Text] [Related]
40. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
